The Comorbidity of Lung Cancer and ILD: A Review.

Patients with interstitial lung disease (ILD) and especially with idiopathic pulmonary fibrosis(IPF) suffer from reduced survival expectation and risk of exacerbations. Lung cancer is a relevant comorbidity in ILD patients and associated with impaired survival.The most frequent ILD among patients with NSCLC (Non-small cell lung cancer) is idiopathic pulmonary fibrosis (IPF), which is associated with an greater decline in lung function and a higher risk of death.

Comparative Economic and Life Cycle Analysis of Future Water Supply Mix Scenarios for Hong Kong - A Water Scarce City.

Increasing urbanization and changes in climate have placed increasing stress on urban water supply systems. Policy makers have increasingly adopted alternative water supply sources, such as desalination and water reclamation to meet this challenge, however these technologies may increase the negative environmental impacts of the water supply system. These alternative sources are energy intensive, and more expensive to produce, which raises questions about their sustainability.

Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patients.

Background: Etoposide-/platinum-based chemotherapy is the standard first-line treatment for extensive-disease small cell lung cancer (SCLC), but responses are short-lived and subsequent options limited. Here, we present our experience with paclitaxel in advanced treatment lines.

Methods: We retrospectively studied the clinical course of all paclitaxel-treated SCLC patients between 2005 and 2015 in our institution.

Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation.

Objectives: Patients with brain metastases from small-cell lung cancer (SCLC) who underwent prior prophylactic cranial irradiation (PCI) are often treated with a second course of whole brain radiation therapy (Re-WBRT) or stereotactic radiosurgery (SRS) for purposes of palliation in symptomatic patients, hope for increased life expectancy or even as an alternative to untolerated steroids. Up to date there is only limited data available regarding the effect of this treatment. This study examines outcomes in patients in a single institution who underwent cerebral re-irradiation after prior PCI.